E31.20

Clinical Causes: Genetic mutations: Most cases of MEN syndrome are inherited due to mutations in specific genes involved in cell growth regulation. Family history: A family history of MEN syndrome increases the likelihood of developing the condition. Rarely, spontaneous genetic mutations can occur without a family history.

Key Symptoms: Presence of tumors in the parathyroid glands, leading to overproduction of parathyroid hormone (hyperparathyroidism). Tumors in the pituitary gland that may cause symptoms such as headaches, vision changes, or hormonal imbalances. Tumors in the pancreas, which may produce excess hormones leading to symptoms like abdominal pain, weight loss, or symptoms related to hormone excess (e.g., insulin, gastrin). Additional symptoms depend on the specific glands affected and the hormones involved. Possible development of malignant tumors in endocrine glands, which may present as new or enlarging masses or related systemic symptoms.

Diagnosis Path: Diagnosis of MEN syndrome involves a combination of medical history, physical examination, biochemical tests, imaging studies, and genetic testing. Healthcare providers may perform blood and urine tests to check hormone levels, as well as imaging procedures such as MRI, CT scans, or ultrasound to identify tumors. Genetic testing can identify mutations associated with MEN, aiding in confirming the diagnosis and screening family members.

Treatment Protocols: Surgical removal of tumors or affected glands to reduce hormone overproduction or eliminate tumors. Medications to manage hormone levels or symptoms, such as hormone-blocking drugs or suppressants. Regular monitoring and follow-up to detect new tumors or recurrences early. Targeted therapies or chemotherapy for malignant tumors, if present. Genetic counseling for patients and their families to understand inheritance patterns and screening options.